Inovio Pharmaceuticals
INO
#9231
Rank
NZ$0.29 B
Marketcap
NZ$2.68
Share price
24.28%
Change (1 day)
-29.89%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2023 (TTM): NZ-$1.06

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.25. In 2022 the company made an earnings per share (EPS) of NZ-$2.09 an increase over its 2021 EPS that were of NZ-$2.57.

EPS history for Inovio Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.06-49.16%
2022NZ-$2.09-18.62%
2021NZ-$2.5734.26%
2020NZ-$1.92-10.74%
2019NZ-$2.1515.24%
2018NZ-$1.86-0.94%
2017NZ-$1.884.95%
2016NZ-$1.79129.55%
2015NZ-$0.78-29.03%
2014NZ-$1.10-55.71%
2013NZ-$2.48141.38%
2012NZ-$1.0320.83%
2011NZ-$0.85-25%
2010NZ-$1.14-56.76%
2009NZ-$2.6323.33%
2008NZ-$2.1311.11%
2007NZ-$1.92-41.3%
2006NZ-$3.26-67.14%
2005NZ-$9.93115.38%
2004NZ-$4.61-62.21%
2003NZ-$12.21186.67%
2002NZ-$4.26-0%
2001NZ-$4.26-21.05%
2000NZ-$5.39-58.7%
1999NZ-$13.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.86-465.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.31-386.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.50 69.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.76-154.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.10-257.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$5.91 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA